Author: The Fix

  • Which US City's Residents Spend The Most On Alcohol?

    Which US City's Residents Spend The Most On Alcohol?

    A recent survey found that residents of one popular US city spend more than $1,000 on alcohol annually.

    People in San Francisco spend more money on alcohol than residents of any other U.S. city—dropping an average of $1,131 per year (or 1.5% of their annual pay) on beer, wine and liquor, according to SF Gate

    The finding emerged from data on Americans’ spending on alcohol compiled by Delphi Behavioral Health Group from the U.S. Bureau of Labor Statistics’ Consumer Expenditure Survey.

    The analysis found that nationally, Americans spend $484 per year on alcoholic beverages. Spending on alcohol had increased 56.6% since 1996. 

    However, that doesn’t necessarily mean people are consuming more, according to Matthew Insco, who works at the Bureau of Labor Statistics.

    “(Something) to keep in mind—these figures show how much households spend, not necessarily how much they consume,” he said. “For example, one area could drink less but spend more by buying more expensive types of alcohol.”

    The analysis by Delphi found that wine prices have increased more than 150% since 1996, and beer prices have increased by 61%. 

    “These price spikes suggest that rising costs account for much of the increase in Americans’ alcohol spending: People may not be drinking more frequently, but they’re definitely paying more for the privilege of the pint,” the report noted. 

    The report authors also noted that the average spending could be deceptively low. Given that more than a quarter of Americans don’t drink at all, those who do imbibe are spending more than it seems at first glance. 

    “Assuming that this sober cohort spends no money on alcohol, those who do drink likely spend considerably more than $484 annually on average,” the report said. 

    Adults between the ages of 25 and 64 all spend an average of about $540 annually on alcohol, with older and younger adults spending less. People with master’s degrees or higher spend the largest percentage of their income on alcohol. 

    After San Francisco, Minneapolis and San Diego residents spend the most on alcohol at $852 and $850 respectively. Residents in Tampa, Dallas-Fort Worth and Atlanta spend the least, at $411, $373 and $291.

    Surprisingly, New York and Chicago residents also have relatively low spending, at $446 and $492. 

    Americans spend more on alcohol than they do on smoking or tobacco. They also spend four times as much on alcohol as they do on reading. 

    “While none of these cities lack for establishments serving or selling liquor, residents spent less than $500 a year on drinking on average,” the report said. 

    View the original article at thefix.com

  • Whistleblower Alleges Tesla Covered Up Employee's Drug Dealing Ties

    Whistleblower Alleges Tesla Covered Up Employee's Drug Dealing Ties

    Whistleblower Karl Hansen alleges that raising those concerns to Tesla management was what got him fired in mid-July.

    Last week, a former Tesla security employee filed an explosive tip with the Securities and Exchange Commission, claiming the company hacked employee cell phones and turned a blind eye to drug dealing and large-scale theft at the Nevada Gigafactory.

    Whistleblower Karl Hansen claimed that raising those concerns to Tesla management was what got him fired mid-July, according to The Mercury News. Hansen lodged his complaint with the feds on August 9, according to his attorney Stuart Meissner, of the New York-based firm Meissner Associates. 

    The sweeping complaint claims that Tesla spied on its own workers by wiretapping their phones and hacking their computers, including those of another recently axed whistleblower, Martin Tripp. 

    Hansen also accused the company of keeping secret the results of its internal probe into a cartel-connected coke- and meth-dealing ring that one employee operated out of the Nevada site, a claim to which the DEA supposedly alerted the company.

    On top of that, Hansen alleges that Tesla neglected to disclose information about $37 million worth of raw materials stolen this year, an incident that supposedly led to the firing of another worker who reported it all to police. 

    Tesla fired back against the allegations with its own statement, saying the claims were “taken very seriously” when Hansen came forward with them—but ultimately, the company claimed, they couldn’t be proven. 

    “Some of his claims are outright false,” the company said, according to a statement published by CNBC. “Others could not be corroborated, so we suggested additional investigative steps to try and validate the information he had received second-hand from a single anonymous source.”

    But, Tesla claimed, Hansen refused to keep speaking with the company. 

    “It seems strange that Mr. Hansen would claim that he is concerned about something happening within the company,” Tesla added, “but then refuse to engage with the company to discuss the information that he believes he has.”

    Elon Musk was more to-the-point in his appraisal of Hansen. 

    “This guy is super [nuts],” he wrote in a Twitter DM to a Gizmodo reporter, using the peanut emoji to drive home the point. 

    “He is simultaneously saying that our security sucks (it’s not great, but I’m pretty sure we aren’t a branch of the Sinaloa cartel like he claims) and that we have amazing spying ability,” Musk added. “Those can’t both be true.”

    View the original article at thefix.com

  • Nigerian Girls Win Tech Challenge With Counterfeit Drug Detection App

    Nigerian Girls Win Tech Challenge With Counterfeit Drug Detection App

    The teen team hope that their app can stem the sale of counterfeit medications in their home country.

    A team consisting of five teenage girls from Nigeria has won Silicon Valley’s 2018 Technovation Challenge by building an app that detects counterfeit drugs.

    The app, called FD-Detector, works by scanning the medicine’s barcode and checking is validity and expiration date.

    The victory comes especially as a surprise considering Team Save-A-Soul having limited experience in technological skills–five months prior one of the team’s members, Jessica Osita, never even used a computer, let alone browsed the Internet.

    “I feel very excited and relieved. I’m extremely proud of myself,” Osita said to CNN.

    The teenaged team, composed of Promise Nnalue, Jessica Osita, Nwabuaku Ossai, Adaeze Onuigbo and Vivian Okoye, hope that their app can stem the sale of counterfeit medications in their home country.

    Osita herself had a personal brush with fake drugs. Her brother was involved in an accident and died after being given fake drugs.

    “My brother died from fake drugs. I’m very motivated by the death of my brother to solve this problem,” she revealed. “With this app, we will relieve the burden. I feel very excited.”

    She one day hopes to become a pharmacist.

    “I want to produce genuine drugs,” she said.

    To claim victory, the team had to beat representatives from all over the world, including the United States, Turkey, Uzbekistan, and China in the finals.

    “People are calling us celebrities and taking pictures with us. I’m very happy. We could not have done this without our mentor. She really believed in us and encouraged us,” Nnalue told interviewers.

    Their mentor, Uchenna Ugwu, introduced computers and coding to the girls through her organization, Edufun Technik, which seeks to bring STEM to the underprivileged children of Anambra State in Nigeria.

    “They have experienced so many firsts. They were entering a flight for the first time. The girls were scared and overwhelmed. They asked me, ‘How can we compete with these countries who have been using tech for a very long time?’” Ugwu recalled. “I told them ‘it’s not how long ago you started, but how well you do.’ I’m so proud of them because they were so determined to learn. They were not the most talented in the coding class but they were the most determined. They stuck with the classes when a lot of their peers dropped out.”

    The girls’ project could potentially have a huge impact back home, where Nigerian officials have long been battling counterfeit drugs.

    Just last June, the Nigerian National Agency for Food and Drug Administration and Control had to destroy nearly $10 million in counterfeit drugs.

    Fake drugs are also a problem in the United States. Lethal counterfeit opioid painkillers are growing in the black market. Music legend Prince passed away after taking fentanyl-laced counterfeit Vicodin.

    View the original article at thefix.com

  • Microaggressions: How Subconscious Biases Affect Recovery

    Microaggressions: How Subconscious Biases Affect Recovery

    An example of a microaggression in the recovery universe: someone from NA asks someone who’s considering Suboxone: “Are you in denial? A drug is a drug is a drug.” No malicious intent is involved, but the fellow member is left feeling disparaged.

    Politics and Religion: we’re encouraged to avoid these conversations, socially. Conviction can escalate to hostility, hurt feelings and polarization, turning a fun-loving conversation into… “Awkward.”

    Has anyone noticed polarization-creep migrating from political intercourse into our addiction/recovery discussion? A diversifying recovery community means different tribes and subcultures with differing views on recovery and addiction. Many Fix readers are members of a mutual-aid group that gives a sense of identity and belonging. Being tribal is human nature; so, what’s the problem? Maybe it’s a hangover from the current political climate but I’m feeling a little microaggression-fatigue. It’s great to cheer hard for the home-team; but does that mean diminishing the other(s)?

    “We tribal humans have a ‘dark side,’ ironically also related to our social relationships: We are as belligerent and brutal as any other animal species,” says author and UC San Diego Professor Emeritus Saul Levine, MD, in “Belonging Is Our Blessing, Tribalism Is Our Burden.” “Our species, homo sapiens, is indeed creative and loving, but it is also destructive and hostile.”

    Levine cautions that for all the psychological good that belonging offers us, “Dangers lurk when there is an absence of Benevolence. Excessive group cohesiveness and feelings of superiority breed mistrust and dislike of others and can prevent or destroy caring relationships. Estrangement can easily beget prejudice, nativism, and extremism. These are the very hallmarks of zealous tribalism which has fueled bloodshed and wars over the millennia.”

    How does “zealous tribalism” present in the recovery community? Abstinence-focused tribes have dearly held views that differ from our harm-reduction fellows. Inside the abstinence-model tribe, it’s not all Kum Ba Yah, either. Refuge Recovery clans, SMART Recovery, Women for Recovery and the 12-step advocates may feel a superiority/inferiority thing that comes out in how we talk about each other. SMART followers may look down on 12-stepping as stubbornly old-fashioned. 12-steppers might see Life Ring or other new tribes as acting overtly precious with their dismissal of tried-and-true methods. Focusing in even more, we see NAs, CAs and AAs each rolling their eyes at each other’s rituals or slogans. In AA, secular members and “our more religious members” finger point at each other about who’s being too rigid and who’s watering down the message. These are examples of what Levine calls “belonging without the benevolence.” Finding “our people” is great. Part of what makes us feel included might also over-emphasize the narcissism of small differences.

    “Meeting makers make it!”
    “That’s not sober; that’s dry. The solution is clearly laid out in the 12 steps—not meetings!”
    “AA’s a cult that harms more people than it helps!”

    These are tribal battle cries—sincerely held feeling based in part on our unique lived experience and in part on an ignorance we’re not conscious of.

    If you love the fight and you don’t care what others think of you, this article might not hold your attention. We’re going to talk about how to get along better. On the other hand, if you see yourself as empathetic and regret falling prey to us vs. them conflicts, let’s talk about cause and corrective measures.

    Recovery professionals curb their own biases through professional practices; we can borrow their best practices to avoid getting defensive or dismissive with people who hold divergent worldviews. If our goal is to connect with others, an increasingly diverse world of others presents challenges.

    “In my early career, I was adamant about abstinence as the only viable solution to alcohol and other drug problems,” recalls William White, author of Recovery Rising: A Retrospective of Addiction Treatment and Recovery. As a historian and treatment mentor, White learned from lived-experience, clinical practice, study and research. His 2017 book advocates for treatment professionals to exercise “professional humility and holding all of our opinions on probation pending new discoveries in the field and new learning experiences. Many parties can be harmed when we mistake a part of the truth for the whole truth.”

    If 100% of my knowledge about harm reduction is from harm reduction failures who tell their story of decline in a 12-step meeting, I could “mistake a part of the truth for the whole truth.” What would I know about harm reduction success stories if I only go to 12-step rooms?

    Treatment professionals are adapting to cultural diversity in their practices. Bound by a Code of Ethics, NAADAC (the Association for Addiction Professionals) has embraced the concept of “cultural humility.” Cultural humility is a fiduciary duty for professionals to be sensitive to client race, creed, sexual orientation, gender identity and physical/mental characteristics when providing healthcare.

    “Cultural humility is other-oriented. Cultural humility is to maintain a willingness to suspend what you know or what you think you know based on generalizations about the client’s culture. Power imbalance between counselor and client have no place in cultural humility. There is an expectation that you understand the population you’re serving and that you take the time to understand them better,” explains Mita Johnson, the Ethics Chair for NAADAC, who teaches cultural humility to addiction/treatment professionals. Dr. Johnson says, “Addiction professionals and providers, bound by ethical practice standards, shall develop an understanding of their own personal, professional and cultural values and beliefs. Providers shall seek supervision and/or consultation to decrease bias, judgement and microaggressions. Microaggressions are often below our level of awareness. We don’t always know we are doing it.”

    Microaggression—today’s buzzword—google it. In The Atlantic’s “Microaggression Matters,” Simba Runyowa elaborates on the insidiousness of this behavior: “Microaggressions are behaviors or statements that do not necessarily reflect malicious intent, but which nevertheless can inflict insult or injury. … microaggressions point out cultural difference in ways that put the recipient’s non-conformity into sharp relief, often causing anxiety and crises of belonging on the part of minorities.”

    Here’s how that might look in our recovery universe: someone from NA, a complete abstinence-based fellowship, asks someone who’s thinking about medication-assisted treatment with Suboxone: “Are you in denial? A drug is a drug is a drug.” No malicious intent is involved but the fellow member is left feeling disparaged. Maybe the well-intended NA had a negative experience with medically assisted treatment (MAT) and has a visceral feeling about it, “Taking drugs to stop drugs isn’t clean.” But NA doesn’t work for everyone. Yours or my anecdotal experience will bias us. Maybe expressing my own personal experience, or just listening without commenting, would be more culturally humble.

    The same is true of the MAT fan who says, “12-steppers are deluded by a faith-healing 80-year-old modality; only five-percent of people get helped from the 12 steps.” These types of arguments are not other-oriented. This is tribalism. 

    A simplistic solution to avoiding lane-drift is to listen more and share in first person. Prescriptive communicating—as opposed to a descriptive narrative—will, inadvertently, engage us in microaggression.

    Just when “Why can’t we all just get along” seemed hard enough, there’s more than one subconscious microaggression we need to be aware of. Derald W. Sue, Ph.D., a psychology professor at Columbia University, describes three microaggressions: micro–assaults, micro–insults and micro–invalidations.

    Micro–assaults are most akin to conventional discrimination. They are explicit derogatory actions, intended to hurt. Here’s an AA example: disparaging a humanist AA in a meeting by quoting Dr. Bob’s 1930s view, “If you think you are an atheist, an agnostic, a skeptic, or have any other form of intellectual pride which keeps you from accepting what is in this book, I feel sorry for you.” No one feels “sorry for” their equal. Inferiority is implied.

    “A micro–insult is an unconscious communication that demeans a person from a minority group,” Dr. Sue reports. Using another 12-step creed-based example, “CA includes everyone; it’s ‘God as you understand Him.” Who is likely to feel demeaned by Judeo/Christian-normative language?

    We could rightfully credit 1930s middle-America Alcoholics Anonymous founders for their progressive—always inclusive, never exclusive—posture; “everybody” in 1939 America meant Protestants, Catholics and Jews. The AA of the 1930s was culturally humble. Today, inadvertently, this same language is less effective at gateway-widening. Today, just 33% of earthlings embrace this interventionist higher power of the early 12-step narrative. According to the Washington Times, globally, 16% of people have no religion and 51% have a non-theistic, polytheistic faith. Sikhs or Muslims may share monotheism, but they worship a genderless deity; no room for “Him” of any understanding. Cultural humility accommodates all worldviews, without asking others to speak in the language of the majority.

    “Minimizing or disregarding the thoughts, feelings or experiences of a person of color is referred to as micro–invalidation.” This is how the American Psychiatric Association rounds out Dr. Sue’s three types of microaggression. “A white person asserting to minorities that ‘They don’t see color’ or that ‘We are all human beings’ are examples.”

    Disregarding or minimizing in our community might be telling someone: “You can participate in your online groups if you like but don’t treat InTheRooms.com like real meetings. Face-to-face is the only way to connect with real people.” If expressed in first person, instead of disregarding the other, the message could relate a personal experience and an informed belief. Have we learned everything about the person we’re talking to? Social anxiety disorder or a dependent partner, parent or child at home could be reasons why the online meeting is the superior option for them.

    To William White’s point, what do I really know about the comparative benefits of online community vs. traditional meetings? Maybe I could consider his informed advice of “holding all of our opinions on probation pending new discoveries in the field and new learning experiences.”

    Mita Johnson identifies a challenge with microaggression—it’s subconscious. How do we correct subconscious behaviors? Dr. Sue authored a couple of books to help combat microaggression at an individual, institutional and societal level: Microaggressions in Everyday Life: Race, Gender and Sexual Orientation and Microaggressions and Marginality. Sue offers five steps to help connect us with more varieties of addicts/alcoholics. “Microaggressions are unconscious manifestations of a worldview of inclusion, exclusion, superiority, inferiority; thus, our main task is to make the invisible, visible.” Here are Dr. Sue’s five practices:

    1. Learn from constant vigilance of your own biases and fears.
    2. Experiential reality is important in interacting with people who differ from you in terms of race, culture, ethnicity.
    3. Don’t be defensive.
    4. Be open to discussing your own attitudes and biases and how they might have hurt others or revealed bias on your part.
    5. Be an ally. Stand personally against all forms of bias and discrimination.

    I gave it a try. Taking inventory—in these five ways—of my prejudices and preconceived ideas helps identify my insensitivities. It helps thinking/acting more other-oriented. Secondly, more than ever, it’s a good time for more active listening and less instruction. Getting defensive, even to microaggression coming my way, escalates the divides. Admitting my assumptions and the faulty conclusions is a version of “promptly admit it” that is so familiar. Finally, how can I “Be an ally?” It’s not hard, today, to stand up for myself when I’m being disrespected. Now will I say something when someone else is being invalidated, insulted or dismissed? Yes, there’s a time to mind my own business but if I’m committed to “be an ally,” can I stay silent when another is being ganged up on by the tyranny of the majority?

    When I’m tempted to be tribal when confronted with other individuals or recovery groups, I try to remember that all people who suffer from process or substance use disorder have been subjected to microaggressions. William White identifies a few of the more cliché slights we all face:

    • “Portrayals of the cause of substance use disorders as personal culpability (bad character) rather than biological, psychological, or environmental vulnerability.
    • Imposed shame, e.g., being explicitly prohibited by one’s supervisor from disclosing one’s recovery status out of the fear it would harm the reputation of the company.
    • Misinterpretation of normal stress responses as signs of impending relapse.”

    In this regard there is no us vs. them. Just “us.”

    Not everyone believes that shining a light on microaggression will solve hostilities towards each other. “There are many problems with studies of microaggressions, technical and conceptual. To start, its advocates are informed by the academic tradition of critical theory,” Althea Nagai argues in “The Pseudo-Science of Microaggressions.” Nagai identifies confirmation bias found in almost all focus groups and the problem of unintended consequences when institutionalizing anti-microaggression policy.

    Nagai’s National Association of Scholars article continues, “There is nothing in the current research to show that such programs work. I suspect most fail to create greater feelings of inclusion. Research suggests they create more alienation and sense of apartness. The recent large-scale quantitative studies suggest that increased focus on ethnic/racial identity exacerbates the problems they are supposed to address. In other words, ‘social justice’ and diversity programs may actually backfire, creating less inclusion, more polarization.”

    Dr. Sue cautions us about weaponizing microaggression; other-oriented cultural humility is to take inventory of my microaggressions—not to fault-find other’s behaviors. Social psychologist Lee Jussim in Psychology Today says keep it personal—not global: “To understand how we can all unintentionally give offense through our own ignorance or insensitivity—thereby increasing our ability to make the same points without being hurtful.”

    “I’d rather step on your toes than walk on your grave,” is a rationalization we hear in the rooms. How do I neither pussy-foot around and avoid being a dick? Beyond intellectualizing, cultural humility is introspective. In “Cultural Humility versus Cultural Competence: A Critical Distinction in Defining Physician Training Outcomes,” cues from professionals show me how to re-frame how I interact with others: “Cultural humility incorporates a lifelong commitment to self-evaluation and self-critique to redressing the power imbalance in the patient-physician dynamic and to developing mutually beneficial and non-paternalistic clinical and advocacy partnerships with communities on behalf of individuals and the defined population.”

    For me, this nails how to stay other-focused: Professionals (or anyone who wants to relate to others better) should “relinquish the role of expert and become the student of the patient with a conviction and explicit expression of the patient’s potential to be a capable and full partner in the therapeutic alliance.”

    I don’t need a course or a degree to “become the student” of others. Instead of acting like I know what’s best for others, I can be a fellow traveler; think about other-focused approaches globally; but act locally.

    View the original article at thefix.com

  • Experts Develop Post-Surgery Opioid Guidelines To Curb Overprescribing

    Experts Develop Post-Surgery Opioid Guidelines To Curb Overprescribing

    “Our feeling is we shouldn’t just be using draconian, one-size-fits all prescribing,” said one expert from Johns Hopkins. 

    Surgeons at Johns Hopkins Hospital in Baltimore have developed opioid prescribing guidelines that are specific to 20 common surgeries, in an effort to reduce overprescribing. 

    “This work reflects that surgeons want to be a part of the solution,” Dr. Heidi Overton, a surgery resident at Johns Hopkins who worked on the guidelines, told The Baltimore Sun.

    The guidelines were published this week in the Journal of the American College of Surgeons. Previously, Johns Hopkins doctors generally prescribed a 30-day supply of opioid painkillers following surgery, a standard that was “dangerously high,” according to lead study author Dr. Martin Makary, a professor of surgery and health policy expert at the Johns Hopkins University School of Medicine. 

    The new guidelines take into account what type of surgery a patient had. The panel that made the recommendations suggested one to 15 opioid pills for 11 of the 20 procedures, 16 to 20 pills for six of the 20 procedures, and none for three of the procedures—a drastic reduction from previous prescribing practices. 

    Patients having orthopedic surgeries needed the most opioid painkillers and those having ear, nose and throat procedures needed the fewest, study authors said. Doctors can adjust their prescription based on specific patients’ needs as well. 

    “Our feeling is we shouldn’t just be using draconian, one-size-fits all prescribing,” said Makary. “Everyone is different. Opioid prescribing should fall within a best practices range and currently we don’t do very well with that. Our hope is that this represents a first step in better understanding how we can treat pain better.”

    Makary noted that one in 16 surgery patients become long-term drug users. He also explained that more than half of patients who did not need opioids to manage pain in the hospital are still sent home with a prescription. Because of that, 70 to 80% of opioids prescribed to patients are never used as prescribed.

    Changing standards around opioid prescriptions is part of addressing the current overdose crisis, he said.  

    “We don’t just need treatment and rehab facilities,” Makary said. “We shouldn’t just be cleaning up the floor, but we should be turning off the spigot of overprescribing that doctors did with good intention, but bad science.”

    Other teaching hospitals have tried to implement opioid prescription guidelines, but the American College of Surgeons has not addressed the issue.

    However, the organization is putting together a brochure “to help surgeons facilitate a dialog with their patients on postoperative pain relief.”

    View the original article at thefix.com

  • Opioid Crisis Has Peaked, Former Cleveland Clinic CEO Suggests

    Opioid Crisis Has Peaked, Former Cleveland Clinic CEO Suggests

    The doctor says that while opioid prescribing is down, synthetic opioids are now driving the opioid epidemic.  

    The former CEO of the Cleveland Clinic said that the opioid epidemic has peaked now that more healthcare providers and laypeople are aware of the dangers of opioid painkillers.

    “I think we’ve peaked,” Dr. Toby Cosgrove said on CNBC’s Squawk Box. “I think we’re starting to see the understanding of the problem, and getting to the point where people are certainly prescribing fewer drugs and people are recognizing how serious this is.”

    However, he said that synthetic opioids are continuing to drive opioid deaths. 

    “The other issue is that drugs are now being laced with fentanyl and carfentanil, which are highly potent,” said Cosgrove, a cardiac surgeon who led the Cleveland Clinic hospital for 13 years before stepping down in 2017.

    “Carfentanil is 10,000 times as potent as morphine. We just had an outbreak of deaths in Ohio from drugs being laced with very potent carfentanil and fentanyl,” Cosgrove noted.

    Cosgrove now works as an executive advisor to Google Cloud Healthcare and Life Sciences team, and is a proponent for healthcare reform. During his CNBC appearance he talked about ways to reduce healthcare costs.

    He noted that while the United States has the highest healthcare costs in the world, the country is about average in the amount spent on healthcare and social programs combined. He said that this shows that investing in social programs can help alleviate the burden of healthcare costs. 

    “Social programs, frankly, are driving down the healthcare costs” in other countries, he said. 

    Although there has been some leveling of opioid overdose rates in certain areas, the national overdose rate climbed in many places between 2016 and 2017. In fact, 45 states saw opioid overdoses increase 30% between July 2016 and September 2017, according to federal data.

    During that time period, the Midwest—including the area served by the Cleveland Clinic—saw opioid overdose rates increase 70%, driven largely by an influx of synthetic opioids. In fact, fentanyl is a factor in nearly half of opioid-related deaths. 

    As Cosgrove suggested, opioid prescribing is down. However, this isn’t necessarily linked to a reduction in overdose deaths. In fact, West Virginia decreased the amount of opioids prescribed by 12% between 2016 and 2017, but still saw opioid-related overdose deaths rise. Because of this, some medical experts warn that the opioid crisis could continue to get worse before improving. 

    “I think we have to realize that we’re on a trajectory that may get a lot worse before it gets better,” said Donald S. Burke, dean of the University of Pittsburgh’s Graduate School of Public Health. 

    View the original article at thefix.com

  • Does Medical Marijuana Make Workplaces Safer?

    Does Medical Marijuana Make Workplaces Safer?

    A new study examined workplace fatality statistics in states with medical marijuana programs.

    As legalized medical and/or recreational marijuana becomes a reality in the United States and abroad with each passing month, the question of safety in the workplace has become a topic of discussion among businesses and the legal community.

    A new study has directly addressed this issue by examining workplace fatality statistics in states with medical marijuana programs. What researchers found was that among certain demographic groups in states with such programs, there was a decline in the number of such incidents—a number that continued to decrease over a period of five years.

    The study, conducted by researchers from Montana State University, the University of Colorado Denver and American University, and published in the October 2018 edition of International Journal of Drug Policy culled workplace fatality data from all 50 states and the District of Columbia from the years 1992 to 2015.

    The data was obtained from the Bureau of Labor Statistics and adjusted for state demographics, unemployment rate and other factors. For the purposes of the study, the researchers looked at workers in two demographics—individuals between the ages of 16 and 24 and those between 25 and 44.

    As High Times noted, the study found evidence that in states with a legal medical marijuana program, incidents of workplace fatalities in the second age group (25-44) dropped by 19.5%.

    Workers between the ages of 16-24 in those states also saw a reduction, though as the researchers noted, this number was “not statistically significant at conventional levels.” 

    Additionally, the study authors found that states that had an active medical marijuana program for a period of five years saw a 33.7% reduction in the number of expected workplace fatalities.

    And those states that included pain as a qualifying condition to participate in their program were associated with a higher reduction in workplace fatalities among workers 25-44 than those states that did not have a program for a similar length of time.

    High Times pointed to two areas where further studies would benefit the argument for medical marijuana abetting workplace safety. The study does not mention any use of cannabidiol (CBD), which does not produce the euphoric, psychoactive effects of THC.

    Patients who use medical cannabis with cannabidiol have technically used a medical marijuana product but are not “high at work,” as the Times noted; as such, there is no means of measuring their impact on workplace fatalities.

    The study authors also cite the need for further research into studies which have suggested that states with medical marijuana programs have seen decreased use in alcohol, opioids and other substances that can cause physical or cognitive impairment which, in turn, can increase instances of workplace fatalities. But for advocates of legalized marijuana use, the study can be seen as adding to the argument for its safety in workplace scenarios.

    View the original article at thefix.com

  • New York Sues Purdue Pharma Over Opioid Marketing

    New York Sues Purdue Pharma Over Opioid Marketing

    New York plans to work with other states that are investigating opioid manufacturers and distributors in the US.

    This week, New York became the 27th state to sue Purdue Pharma, a producer of OxyContin, for alleged fraud and deception in its marketing of opioids.

    The Wall Street Journal reported that Purdue is the only defendant listed in the lawsuit, driven by the administration under Governor Andrew Cuomo and New York Attorney General Barbara Underwood.

    The complaint was filed in Suffolk County Supreme Court and charged that a community flooded with opioids has been devastated while Purdue has increased profits and prescriptions.

    The suit charges that as of 2016, over 75% of New York’s opioid overdose deaths were caused by painkillers which include Purdue’s product, OxyContin.

    Governor Cuomo was quoted in Insurance Journal as saying, “The opioid epidemic was manufactured by unscrupulous distributors who developed a $400 billion industry pumping human misery into our communities. This lawsuit sends a clear message (to those) who mislead the public to increase their profit margins that we will hold you accountable.”

    Purdue released a response which called New York’s allegations false, while citing that the company also shares the state’s concerns about the opioid crisis.  

    Purdue noted that the U.S. Food and Drug Administration (FDA) “continues to approve” of scientific and medical information it provides to physicians.

    In the suit, New York is seeking civil fines to be levied against Purdue. The state asks to recoup profits the drug company has made and pay fines for what they allege in the Insurance Journal is “criminal nuisance.”

    In 2007, Purdue and three executives pleaded guilty to misbranding OxyContin. The company was charged with $634.5 million after a U.S. Department of Justice investigation.

    The New York lawsuit against Purdue is part of a trend; a number of U.S. states are suing opioid makers and distributors over opioid marketing.

    New York joined 26 other states, and Puerto Rico, in suing Purdue over their allegedly deceptive opioid marketing practices and the resulting health crisis.

    Cuomo released a statement published in the Wall Street Journal that the country is fed up with the practice of pharmaceutical companies purposefully creating addiction for the purpose of profit.

    Barbara Underwood in the Wall Street Journal said that the complaint is only New York’s first step toward holding pharmaceutical companies responsible. “Our work won’t stop with this lawsuit,” she said.

    New York plans to work with other states to investigate United States opioid manufacturers and distributors.

    View the original article at thefix.com

  • More Than 70 People Overdose In Connecticut Park Over 24-Hour Period

    More Than 70 People Overdose In Connecticut Park Over 24-Hour Period

    K2 is to blame for the mass overdose in New Haven.

    Starting on Tuesday night, more than 70 people suffered a drug overdose in a 24-hour period in New Haven, Connecticut—most of them a stone’s throw from Yale University.

    According to CBS News, the Drug Enforcement Administration has confirmed that the cause of the mass overdose was, indeed, K2—the synthetic drug that’s been the suspect behind similar mass drug poisonings from Washington, D.C. to Skid Row.

    Initially, officials speculated that the mystery substance was “possibly laced with an opioid” such as fentanyl, the New York Times reported. But the DEA confirmed that no additives were detected.

    Most of the poisonings happened on New Haven Green, a park not far from Yale University. At least two people experienced “life-threatening symptoms,” but no deaths were reported. Three people were arrested in relation to the mass overdose.

    At the scene, the victims suffered “a multitude of signs and symptoms ranging from vomiting, hallucinating, high blood pressure, shallow breathing, [and] semi-conscious and unconscious states,” said Rick Fontana, New Haven’s director of emergency operations.

    Emergency personnel scrambled to reach all of the victims. They were “sprinting from patient to patient in the park,” with crews transporting people quickly “just to turn the cars around and get them back out,” according to Dr. Sandy Bogucki, the city’s director of emergency medical services.

    On July 4, there were 14 drug overdoses in the same area of New Haven, with K2 as the reported cause.

    Also in July, NBC News reported that more than 260 people were sickened by “synthetic drugs” in Washington, D.C. in a span of 10 days. Once again, K2 was the suspected cause.

    This marked a significant increase from the previous July, when just 107 were hospitalized for drug poisonings in Washington, D.C.

    K2 is also known as Spice and “synthetic marijuana.” However, as High Times notes, comparing the drug to cannabis is “being generous.”

    The only similarity that K2 may have to cannabis, however faint, is its physical appearance. But the effects couldn’t be more different.

    “In reality, the drug is a manmade chemical cocktail of various psychoactive substances,” High Times explains. “The chemical mixture is then sprayed onto dried herbs or plant material, giving the drug an appearance similar to botanical cannabis.”

    View the original article at thefix.com

  • Jenna Jameson Talks Struggle To Lose Weight In Sobriety

    Jenna Jameson Talks Struggle To Lose Weight In Sobriety

    “I kept telling myself if I could beat addiction and stay sober, I can easily lose the weight… and I did. The healthy way.”

    Jenna Jameson has made some major lifestyle changes — again. 

    According to People, the 44-year-old former adult film actress, who has been outspoken about her sobriety, struggled to lose weight after giving birth to her daughter in April 2017. But on Monday, Aug. 13, she shared a before and after photo on Instagram

    “Let’s talk about the mental aspect of losing weight and getting healthy,” she wrote. “I’m going to be honest with you, when I was heavy I hated leaving the house. I felt judged. I felt eyes on me everywhere. I could hear others internal monologue saying ‘damn, Jenna Jameson let herself go’ ugh…All of us do this, we worry so very much how we are perceived. But beyond that shallow thinking there was deeper shame. I was disappointed in myself.”

    Jameson also referenced her history of substance use disorder, stating that she wasn’t sure how she could lose weight while sober. 

    “I was worried I couldn’t lose the weight Sober,” she wrote. “I’m being real with you. When I was in my addiction it was easy to stay thin. Sobriety and being overweight was new to me. I kept telling myself if I could beat addiction and stay sober, I can easily lose the weight… and I did. The healthy way.”

    Prior to her recent post, Jameson also shared on Instagram that she has been on the ketogenic diet, which, according to Women’s Health, is a diet that involves decreased intake of carbohydrates and increasing fats. 

    “On the right I weight 187,” Jameson wrote on Instagram. “On the left I’m a strong 130. I was lethargic and struggled with the easiest of tasks like walking in the beach sand with Batelli. I felt slow mentally and physically. I took the pic on the right for a body positive post I was going to do and decided against it because I felt anything but fucking positive. I’m now a little under 4 months on the #ketodiet and it’s not only given me physical results, I feel happier, smarter, and much more confident.”

    Now, Jameson says, she feels better not only physically, but mentally as well.

    “And as of today I can say my mental game is STRONG,” she added on Instagram. “I feel I can do anything, I conquered abuse, addiction, PTSD and depression. Thank you for listening and please tell me your stories below, I read every comment.” 

    View the original article at thefix.com